Logo image
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative (Nature Reviews Rheumatology, (2023), 19, 12, (805-817), 10.1038/s41584-023-01045-w):Nature Reviews Rheumatology
Journal article   Peer reviewed

Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative (Nature Reviews Rheumatology, (2023), 19, 12, (805-817), 10.1038/s41584-023-01045-w):Nature Reviews Rheumatology

A.G.S Oldroyd, J.P Callen, H Chinoy, L Chung, D Fiorentino, P Gordon, P.M Machado, N McHugh, A Selva-O’Callaghan, J Schmidt, …
Nature Reviews: Rheumatology, Vol.20(5), 315
2024

Abstract

adult cancer screening clinical study controlled study diagnosis drug therapy erratum female Germany human idiopathic inflammatory myopathy male malignant neoplasm myositis rheumatology
In the version of the article initially published, two affiliations for Jens Schmidt were missing and have now been added as affiliations 16 and 17 in the HTML and PDF versions of the article: Department of Neurology and Pain Treatment, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany and Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany. © Springer Nature Limited 2024.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.106 Rheumatology
1.106.1684 Dermatomyositis
Web Of Science research areas
Rheumatology
ESI research areas
Clinical Medicine
Logo image